In addition to its diagnostic value, elevated CEA has also been proposed to be associated with poor prognosis in patients with pancreatic cancer (Lin et al., 2017; O’Brien et al., 2015). The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.